An HIV vaccine trial that started in 2016 in South Africa was halted in February 2020. The study sponsors made the call after interim results showed that the vaccine, known as HVTN 702, did not prevent HIV. This result was ...
Feb 13, 2020
1
2
Less than one in four adolescent men who have sex with men (AMSM) ever get tested for HIV, research funded by the National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health, ...
Feb 12, 2020
0
0
Adding maraviroc to standard combined antiretroviral therapy (c-ART) does not seem to improve clinical outcomes for patients initiating treatment for advanced HIV infection. Findings from a double-blind randomized controlled ...
Feb 11, 2020
0
2
The majority of teenage boys most at risk for developing HIV are not being tested for the disease, reports a new Northwestern Medicine study. This lack of testing feeds the growing epidemic of undiagnosed HIV infections in ...
Feb 11, 2020
0
26
Mathematicians from RUDN University have developed a computational model that allows predicting the mobility of T-lymphocytes, immune cells that recognize and destroy viruses. The model will help in the treatment of immune ...
Feb 5, 2020
0
4
Antiretroviral drugs are the gold standard for the treatment of HIV infection. They are highly effective in suppressing replication of the virus but require lifelong daily application and can be associated with side effects. ...
Jan 31, 2020
0
2
The mechanism behind how HIV can develop resistance to a widely-prescribed group of drugs has been uncovered by new research from the Crick and Dana-Farber Cancer Institute, with the findings opening the door to the development ...
Jan 30, 2020
0
223
From 2010 to 2017, use of the HIV-1/HIV-2 differentiation test increased, but the number of HIV-2 diagnoses remained very low, according to research published in the Jan. 24 issue of the U.S. Centers for Disease Control and ...
Jan 24, 2020
0
3
Areas of high HIV prevalence, known as 'hotspots', do not necessarily fuel the epidemic in the wider population, say researchers.
Jan 14, 2020
0
13
Lengthy negotiations ended in good news recently when the price of rifapentine, a lifesaving antibiotic, was marked down by 66% by its manufacturer Sanofi. When combined with another antibiotic (isoniazid), rifapentine can ...
Jan 14, 2020
0
3
